Passionate about making a profound impact on peoples’ lives
Assembly Bio is an ambitious biopharmaceutical company with cutting-edge therapeutic candidates capable of improving the lives of millions living with devastating viral diseases. We have multiple ongoing clinical programs focused on the development of novel antivirals to treat herpesviruses, hepatitis delta virus (HDV) and hepatitis B virus (HBV). Further, our research organization is dedicated to the discovery of new therapies to change the treatment paradigm for viral infections.
Advancing the treatment paradigm for serious viral diseases
Assembly Bio’s team is focused on advancing treatment options for people through the discovery and development of novel antivirals. We are leveraging our extensive expertise in virology to deliver breakthrough therapeutics with the potential to improve outcomes for individuals struggling with the impacts of serious viral diseases.
Board of Directors
Chairman of the Board, Non-Executive
Director
Director
Director
Director
Director
Director
Director
Director
Chief Executive Officer & President, Director
Contact Us
FOR GENERAL INFORMATION,
PLEASE CONTACT:
833.509.4583
info@assemblybio.com
FOR QUESTIONS ABOUT COLLABORATION
OPPORTUNITIES, PLEASE CONTACT:
BD@assemblybio.com